Novel polymorphisms in CYP4A22 associated with susceptibility to coronary heart disease
Open Access
- 4 March 2024
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 17 (1) , 1-10
Abstract
Coronary heart disease (CHD) has become a worldwide public health problem. Genetic factors are considered important risk factors for CHD. The aim of this study was to explore the correlation between CYP4A22 gene polymorphism and CHD susceptibility in the Chinese Han population. We used SNPStats online software to complete the association analysis among 962 volunteers. False-positive report probability analysis was used to confirm whether a positive result is noteworthy. Haploview software and SNPStats were used for haplotype analysis and linkage disequilibrium. Multi-factor dimensionality reduction was applied to evaluate the interaction between candidate SNPs. In overall and some stratified analyses (male, age ≤ 60 years or CHD patients complicated with hypertension), CYP4A22-rs12564525 (overall, OR = 0.83, p-value is 0.042) and CYP4A22-rs2056900 (overall, OR = 1.22, p-value is 0.032) were associated with the risk of CHD. CYP4A22-4926581 was associated with increased CHD risk only in some stratified analyses. FPRP indicated that all positive results in our study are noteworthy findings. In addition, MDR showed that the single-locus model composed of rs2056900 is the best model for predicting susceptibility to CHD. There are significant associations between susceptibility to CHD and CYP4A22 rs12564525, and rs2056900.Keywords
This publication has 30 references indexed in Scilit:
- Age and ageing cardiovascular collection: blood pressure, coronary heart disease and heart failureAge and Ageing, 2022
- A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort studyEuropean Heart Journal, 2022
- Conflicting roles of 20-HETE in hypertension and renal end organ damageEuropean Journal of Pharmacology, 2018
- 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter BindingThe Journal of Pharmacology and Experimental Therapeutics, 2016
- Additive influence of genetic predisposition and conventional risk factors in the incidence of coronary heart disease: a population-based study in GreeceBMJ Open, 2014
- Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive ratClinical Science, 2013
- CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease—The ENCORE TrialsAtherosclerosis, 2009
- Penalized solutions to functional regression problemsComputational Statistics & Data Analysis, 2007
- Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin IIAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
- Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20‐HETE which enhances L‐type Ca2+ currentThe Journal of Physiology, 1998